chrisvoncsefalvay/vaers-outcomes huggingface dataset:
diagnosed with a blood clot in her leg; got really sick.; was hot and cold; had sweating episodes; had a tumble over a board where she hit her leg and it bruised.; she hit her leg and it bruised.; A  week and a half after the fall her  leg was swelling.; missed several days from work; Every single joint on her body ached; had a fever; This spontaneous case was reported by an other health care professional and describes the occurrence of THROMBOSIS (diagnosed with a blood clot in her leg) in a 50-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 091D21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On 28-Jul-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced THROMBOSIS (diagnosed with a blood clot in her leg) (seriousness criterion medically significant), ILLNESS (got really sick.), FEELING OF BODY TEMPERATURE CHANGE (was hot and cold), HYPERHIDROSIS (had sweating episodes), FALL (had a tumble over a board where she hit her leg and it bruised.), CONTUSION (she hit her leg and it bruised.), PERIPHERAL SWELLING (A  week and a half after the fall her  leg was swelling.), IMPAIRED WORK ABILITY (missed several days from work), ARTHRALGIA (Every single joint on her body ached) and PYREXIA (had a fever). At the time of the report, THROMBOSIS (diagnosed with a blood clot in her leg), ILLNESS (got really sick.), FEELING OF BODY TEMPERATURE CHANGE (was hot and cold), HYPERHIDROSIS (had sweating episodes), FALL (had a tumble over a board where she hit her leg and it bruised.), CONTUSION (she hit her leg and it bruised.), PERIPHERAL SWELLING (A  week and a half after the fall her  leg was swelling.), IMPAIRED WORK ABILITY (missed several days from work), ARTHRALGIA (Every single joint on her body ached) and PYREXIA (had a fever) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   There was no concomitant medication reported. There was no treatment medication reported. Also reported information included, 25th is the due date for second dose.  Company comment: Based on the current available information and temporal association between the use of the product and the start date of the events, a causal relationship cannot be excluded. However, more information is required for further assessment.; Sender's Comments: Based on the current available information and temporal association between the use of the product and the start date of the events, a causal relationship cannot be excluded. However, more information is required for further assessment.
Starting 12/31/2022, I woke up with a lot of post nasal drip, congestion, headache and a slight sore throat. I tested myself with an at-home COVID-19 test and that came back negative. The symptoms got worse and the next day (01/01/2023) I tested myself again at home and it was positive. I called the doctor then, but due to it being the weekend and a holiday, they told me to hydrate and take vitamin C and vitamin D. She said to call into the office on Tuesday 01/03/2023. They called me that day and set up a telehealth visit for an hour later. I was prescribed PAXLOVID and told to stop the statins while taking the PAXLOVID. I got the lower dose of the PAXLOVID. To this day, I still have post nasal drip and a little congestion, but no headache or sore throat. I am still testing positive as of yesterday. I will test again on Thursday. The worst symptom I experienced was the sore throat.
SLUGGISHNESS THE DAY AFTER; FEVERISH IN THE NIGHT OF VACCINATION; This spontaneous report received from a consumer via a company representative concerned a male of unspecified age. The patient's weight, height, and medical history were not reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, intramuscular, batch number: Unknown,  expiry: UNKNOWN) .5 ml, administered on 06-MAR-2021 for prophylactic vaccination. The batch number was not reported and has been requested. No concomitant medications were reported. On MAR-2021, the subject experienced feverish in the night of vaccination. On 07-MAR-2021, the subject experienced sluggishness the day after. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The outcome of the feverish in the night of vaccination and sluggishness the day after was not reported. This report was non-serious.
On March 30th, the first skin rash / bump appeared on my right wrist and was very itchy. It expanded to an area about 1 inch x 2 inches and a week later continues to be itchy. Zyrtec helps reduce the itching (I only take 1/8 of a pill because a whole pill is too strong for me) On April 4, three additional spots about  1/2 inch in diameter appeared on and around my right nipple. Later that day, three other spots about 1/2 inch in diameter appeared on my LEFT shoulder. I got the short in my right arm. The chest and shoulder spots are only slightly itchy. I took pictures - hopefully later in this interview, I will be able to upload them.
Mild sore or stiff neck on same day as shot. Sore arm in location of shot the day after the shot. Soreness in the size of a softball around the shot location.
I administered 1 ml. the correct dose is 0.5 ml.  Patient has no adverse event.
This patient sign up to receive a booster dose of the covid vaccine at a community clinic .   Patient attended the clinic with her mother.  She was administered a booster dose of Moderna vaccine before staff realized she was only 16 and under the recommended age of 18 for the Moderna vaccine.  Patient received the Pfizer vaccine for her first two doses of the vaccine.  Mother did sign consent for patient to receive the vaccine.  Patient was observed for 15 minutes after vaccine administration and no adverse reactions were noted.
Patient presented 5/5/21 with pain in Right deltoid area. Area slightly swollen. Suggested he ice area and take anti-inflammatory medication
Patient received the Moderna booster today at 3 pm and waited for fifteen minutes to be monitored in the clinic. After her fifteen minutes were completed, she exited the building and experienced photophobia. She stated that she "noticed lights kinda like when you develop a migraine" or "when you go to the eye doctor and your eyes are dilated." This photophobia was only present in her right eye and intensified over the course of her drive home. She became concerned because it was becoming difficult to see clearly out of the eye. She called to report the side effect. By the time she called at 3:34 pm, her symptom decreased significantly. She stated that she still noticed the photophobia somewhat, but that it was a lot better. She denied any other symptoms including symptoms of anaphylaxis: shortness of breath, rash, lightheadedness, pain and nausea etc.
Fever >102F, myalgias, headache, chills, and site soreness. Unable to go to work.
4/21/2021 was my 2nd vaccine and on 4/23/2021 I experienced extreme pain in both feet, both ankles and left knee. There was some swelling, redness and warmth to the touch. Pain was so severe I had to walk with the assistance of crutches.  On 4/27/2021 started with steroids. I did 2 rounds of steroid treatment and each time the symptoms returned after completing the pack. On 5/11/2021 started taking 15mg of Meloxicam and took that until 5/21/2021 when symptoms finally started to subside.
Pateint came in to COVID vaccine clinic requesting a COVID vaccine. He prefered Moderna. He filled out the paperwork. I asked him some questions to verify. I gave the Moderna shot to Right Deltoid. After Patient left following his 15 minute wait, I was putting his vaccine information into CIIS. Upon putting the information in he had already had his 2 doses of Moderna. I immediately called the patient who stated "Yes, we knew we already had the 2 doses but felt we needed a third. "Spoke to him about it not being FDA approved and not needed as he had completed the series. He stated he knew it was wrong to lie but did it anyway. Informed him that a report w would be filled and side effects after a 3 dose were unknown and to contact his PCP or 911 for adverse reactions. He again apologized for lying.
Fever of 100.3 on 9/26/01. Fever down to 96.9 on 9/57/01. Rash began on 9/26 on feet then moved to chest, axilla, ankles face.
Complained of migraines related to anthrax developing post 3rd vax in series. Approximately 4-5 migraine episodes. No historically triggering events noted. No family history of migraines; no prior history of migraines. Responded promptly to SQ Imitrex during episode.
Extreme fatigue; This is a spontaneous report from a non-contactable other healthcare professional. A 54-year-old female patient received the first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Batch/lot number: EH19899, expiry date not reported), intramuscular on 04Jan2021 11:00 at a single dose on right arm for COVID-19 immunization. Medical history included Prior type 2 diabetic, high cholesterol, and an OTC allergy. Concomitant medication included semaglutide (OZEMPIC), sertraline (SERTRALINE), fish oil (OMEGA 3 ELITE), biotin (BIOTIN), ergocalciferol (VIT D), l-lysine [lysine] (L-LYSINE [LYSINE]), chromium (CHROMIUM). The patient previously took l-lysine [lysine] and experienced allergies. The patient experienced extreme fatigue on 05Jan2021 07:30. No treatment received for the adverse event. The outcome of the event was recovering. The patient was not pregnant at the time of vaccination. The facility where the most recent COVID-19 vaccine was administered was Workplace clinic. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient has not been tested for COVID-19. The event was assessed as non-serious.  No follow-up attempts are possible. No further information is expected.
No additional AE.; HCP reporting a patient was administered expired VAQTA. The VAQTA expired on 4JUN2021, but the patient received the VAQTA on 17AUG2021.; This spontaneous report was received from a nurse and refers to a patient with unknown age or gender. The patient's concurrent conditions, medical history and concomitant medications were not reported.  On 17-AUG-2021 (onset date also reported as 21-AUG-2021), the patient was vaccinated with hepatitis a vaccine, inactivated (VAQTA) 0.5 ml, lot # T008697 (route of administration was not provided) for prophylaxis, which expired on 04-JUN-2021 (expired product administered). It was unknown if the hepatitis a vaccine, inactivated (VAQTA) had any previous temperature excursions. No additional adverse event information provided.
After being brought home from the doctor, where he received a round of shots, he went into anaphalactic shock and had to be rushed to the hospital.
Patient was accidentally splashed in the right eye with a minute amount of hepatitis A vaccine while the medical assistant was removing a bubble from the syringe. The patient's right contact was removed and her right eye received a 15 minute rinse with sterile saline. The physician was contacted. The data safety sheet was reviewed. GSK was contacted as well. This dose not given in arm. A new syringe of Hep A was given in the right arm.
Fever 101 + on 10-12-2013 to 10-15-2013. Rashes on 10-14-2013. Urticarial type rashes noted 10-17-2013.
Rash and mild fever X 2 days started 15July2009 1 day after the shot. Pt was advised to see provider, pt called for telephone consults.
Patient developed severe dizziness, sweating, and became very pale as soon as the pharmacist gave him the injection. We put the patient on the floor and elevated his legs and feet. His color came back to normal. Paramedics were dispatched because of his underlying medical condition. Paramedics checked his blood sugar and it was 145. Patient became very dizzy again when paramedics helped him to sit in a chair so patient decided to go to hospital with them to be checked out.
Date of Admission: 10/28/2022   Date of Discharge: 11/1/2022   Admission Diagnosis: Hypokalemia  Covid Infection    Hospital Principal Problem (Discharge Diagnoses): Hypokalemia
Pt was given flu vaccine in (L) arm and hep A in (R) noted redness around (L) arm injection site. It was worse on 10-26-2011.
This spontaneous report as received from a other health professional refers to a patient of unknown age and gender. The patient' medical history and concurrent conditions were not reported. On 11-SEP-2017, the patient was vaccinated with a dose of improperly stored VARIVAX lot # N017699, expiration date 09-JUN-2017 (route and anatomical location were not reported) for prophylaxis. A sterile diluent (MRK) used for reconstitution was properly stored. Time frame and temperature of excursion were not reported. It was not reported if there were previous temperature excursions. Digital data logger was not involved.
This spontaneous report was received from a nurse regarding a 15 year old male patient. There was no information on pertinent medical history. The patient had a current condition of sulfa allergy. On 03-JUL-2014, the patient was vaccinated with first dose of GARDASIL (Product Lot#J012212) 0.5 ml (milliliters) intramuscularly on right arm (reported as right delt). There was no information on concomitant medications. The reporter stated that she called the patient on an unspecified date on JUL-2014, and it was reported that the patient had redness at the injection site. The patient sought medical attention by visiting health care provider's office. The patient had 3 by 3 inch redness at the injection site of right arm. No swelling, no fever, no headache was reported. The nurse stated that the redness at the injection site looks like sunburn that was peeling. No treatment was given. There was no product quality complaint involved. The outcome of redness at the injection site was reported as not recovered. The causality was unknown. Additional information has been requested.
Gain weight after getting Moderna Vaccine; This case was received via an unknown source (no reference has been entered  on 25-Jul-2021 and was forwarded to Moderna on 25-Jul-2021.    This spontaneous case was reported by a consumer and describes the occurrence of WEIGHT INCREASED (Gain weight after getting Moderna Vaccine) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced WEIGHT INCREASED (Gain weight after getting Moderna Vaccine). At the time of the report, WEIGHT INCREASED (Gain weight after getting Moderna Vaccine) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No concomitant medication was provided by the reporter. No treatment medication was provided by the reporter.   Reporter did not allow further contact
Symptoms include food taste and smells bad, nausea and mouth becomes very watery and feel like throwing up.  Every time I eat my stomach hurts and I feel like I have to go to restroom but nothing comes out.
not adverse event; Customer called and reported that PROQUAD was inadvertently administered to a 46 year old patient. No additional AE reported. No PQC reported. No additional information provided.; This spontaneous report as received from a other health professional refers to a 46 years old patient of unknown gender.   The patient's concurrent condition, medical history and concomitant medication were not reported.   On an unknown date,  the patient was vaccinated with measles, mumps, rubella and varicella (oka-merck) virus vaccine live (PROQUAD) (lot # U039255, expiration date 09-JUN-2023. route was not provided).         It was reported that on 06-APR-2022, that measles, mumps, rubella and varicella (oka-merck) virus vaccine live (PROQUAD) was inadvertently administered to a 46 -year -old patient. No additional AE reported
Achy arm, minimal side effects; Feeling under the weather; This case was reported by a consumer via interactive digital media and described the occurrence of pain in arm in a patient who received Herpes zoster (Shingrix) for prophylaxis.   On 16th January 2023, the patient received the 2nd dose of Shingrix. In January 2023, unknown after receiving Shingrix, the patient experienced pain in arm and feeling unwell. On an unknown date, the outcome of the pain in arm and feeling unwell were unknown.   It was unknown if the reporter considered the pain in arm and feeling unwell to be related to Shingrix.     Additional Information: GSK Receipt Date: 21-JAN-2023 Reporter's Comment: This case was reported by a patient via interactive digital media. The patient had 2nd dose of Shingrix vaccine. The patient had minimal side effects. The patient had achy arm and feeling a little under the weather. The follow-up could not be possible as no contact details were available.
sore arm; This is a spontaneous report from a contactable consumer or other non-health care professional. A male patient of an unspecified age received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Formulation: Solution for injection, Batch/Lot number was not reported), via an unspecified route of administration on an unspecified date as 1st dose, single dose for COVID-19 immunization. The patient medical history and concomitant medications were not reported. The patient experienced sore arm on an unspecified date in 2021. Caller stated that all four of them in the family had sore arm. Everybody said that was to be expected. Her husband gets second one next week. The outcome of the event was reported as unknown.  Information on the lot/batch number has been requested.
First dose just a sore arm and a headache.  Second dose sore arm with redness about 4 inches around injection site. Also, headache and fever.
Child was tested for Pertussis on 6/23/2010 and was PCR Positive.  Culture results pending.
This spontaneous report was received from a physician refers to a female patient of unknown age. On an unknown date when the physician was ready to withdraw a dose of RECOMBIVAX HB (lot # 0908AA, expiration date 05-APR-2014, route not reported) to inject third dose for an adult patient, she found that vial was totally empty and physician did not have an extra vial and patient missed her third dose. No adverse effects reported. Product Quality Complaint (PQC) reported. Additional information has been requested.
suspected vaccination failure; had shingle flare ups; This case was reported by a consumer via interactive digital media and described the occurrence of suspected vaccination failure in a patient who received Herpes zoster (Shingles vaccine) for prophylaxis.   On an unknown date, the patient received Shingles vaccine. On an unknown date, unknown after receiving Shingles vaccine, the patient experienced vaccination failure (serious criteria GSK medically significant) and shingles. On an unknown date, the outcome of the vaccination failure and shingles were unknown.   It was unknown if the reporter considered the vaccination failure and shingles to be related to Shingles vaccine.  Additional details were provided as follows The age at vaccination was not reported. The patient never had shingles but through the advice of their doctor because of his/her age got the Shingles vaccine. Since receiving Shingles vaccine, the patient got had shingles flare ups. The reporter stated that, like any other vaccine, if effects each person differently due to a lot of variables. This case was considered as suspected vaccination failure, since the details regarding the completion of the primary immunization, time to onset for event and laboratory confirmation were not provided. This is 1 of 4 linked case reported by the same reporter.; Sender's Comments:  US-GLAXOSMITHKLINE-US2021AMR184294:Same reporter US-GLAXOSMITHKLINE-US2021AMR184305:Same reporter US-GLAXOSMITHKLINE-US2021AMR184332:same reporter
Joints pain; I looked up to the general symptoms at the injection site and it is joints pain and muscular body aches and in my left hip; I looked up to the general symptoms at the injection site and it is joints pain and muscular body aches and in my left hip; my left leg sometimes I had aches in it; This is a spontaneous report from a contactable consumer. This 80-years-old consumer reported that: A 80-years-old patient of an unspecified gender received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection), dose 2 via an unspecified route of administration on 10Feb2021 (Batch/Lot number was not reported) as DOSE 2, SINGLE for covid-19 immunisation. The patient medical history included Historical Vaccine BNT162B2 for Covid 19 immunization Dose 1 on an unspecified date. The patient's concomitant medications were not reported. The patient experienced Joints pain, the patient looked up to the general symptoms at the injection site and it was joints pain and muscular body aches and in my left hip, the patients left leg sometimes had aches in it on 16Feb2021. There it was bothering the patient ever since Tuesday it was coming and going and my left leg sometimes the patient had aches in it. Patients wanted to know was this a symptom because of the vaccine that was all the patient wanted to know. Consumer was informed about role of Pfizer Drug Safety department. The outcome of event was unknown.  Follow-up attempts are completed. No further information is expected.
Several hours after receiving Oral RotaRix vaccine, 2 month old baby developed fever (100.9-101.2) for four days, acute onset copious watery non-bloody diarrhea (nearly "continuous", needing 3-4 new diapers/hr, per his mom, a very reliable historian) for four days (but still ongoing at time of reporting), and intermittent vomiting (2-4 times/day).  Mom reported that he did have a softer-than-usual stool on the morning before the vaccine, but it was NOT watery and nothing like what he had that afternoon.  At the time of this reporting, the child still has copious diarrhea and is being cared for at home, but I expect he will need hospitalization/IV fluids in the next day or two if this continues.  7/30/09 Hospital records received inpatient DOS 6/26/09 to 6/27/09 ER visit 7/1/09, and inpatient 7/3/09 to 7/10/09. Assessment Gastroenteritis. Fever. Patient presents with 5 days of fever, vomiting, and diarrhea. Stool appears watery, foul smelling. Emesis non-bloody. Maculopapular rash on torso.  Returned with fever, will not drink, sleeping. Called back to ER after discharge for lumbar puncture because of positive blood culture. Readmitted for fever and placed on antibiotics.
Headache; This is a spontaneous report from a contactable consumer (patient). A 61-year-old female patient received the first dose on BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE), on 18Dec2020 at single dose for COVID-19 immunization. Medical history was reported as none. Concomitant medications were not provided. Patient stated that she had her COVID shot on 18Dec2020 (reported as last Friday) and she had a headache ever since. Patient was just taking Ibuprofen trying to get rid of the headache. Outcome of the event was unknown. Information on lot/batch number has been requested.
Information has been received from a nurse practitioner concerning a 17 year old patient who on 04/24/98 was vaccinated with the second dose of Varivax On 03/08/02, the patient developed a chicken pox rash and had pox all over her body, head, scalp, nose, mouth and eyes. When the patient was seen in the physician's office on 03/11/02, she had over 100 pox and a temperature of 103 degree Fahrenheit. The patient was sent to an Ophthalogist for follow-up and was treated with acyclovir (Zovirax) (800 mg PO QID) for five days. The outcome of the event was unknown. Additional information has been requested.